Cancer Reports — Journal Profile & Submission Links
Wiley · ISSN-L 2573-8348
Source-backed journal profile with OpenAlex metadata and links to official submission resources for Cancer Reports.
This page provides a source-backed journal profile and links to official submission resources. Journal instructions can change. Always verify article types, formatting, fees, ethics requirements, and submission rules on the official journal website before submitting.
Official links
- Journal homepage
- onlinelibrary.wiley.com/journal/25738348
- Author guidelines
- onlinelibrary.wiley.com/page/journal/25738348/homepage/forau…
- Submission portal
- mc.manuscriptcentral.com/cancerreports
Catalog scope notes
Philosophy: All sound data and evidence-driven cancer research has value and should be published and shared with the community. Cancer Reports is an international, peer-reviewed, open access journal publishing basic, translational, clinical and interdisciplinary research in cancer biology, diagnosis, treatment, outcome, supportive care, epidemiology and health disparities. The journal considers data-driven, scientifically valid discoveries including: Pilot studies that are scientifically robust preliminary findings conducted to evaluate the feasibility of a large scale study to test innovative new research and theories. Incremental studies that have the potential to add to current knowledge or question existing paradigms, offer new directions or provide valuable insights into existing discoveries. Replication studies that are confirmatory or contradictory to published findings and/or methods reinforcing research reproducibility. Reports on topics with indirect or prospective value to the field of cancer research. Areas covered by Cancer Reports include, but are not limited to: · cancer evolutiona and tumor development · dissemination and metastases · tumor suppressors and oncogenes · cancer immunology · cancer ‘omics’ · tumor microenvironment · cancer systems biology · epidemiology and prevention · experimental therapeutics · drug design and delivery · novel and repurposed anticancer agents · complementary and alternative medicine · mechanisms of drug action and drug-resistance · psycho-oncology · clinical and palliative care and outcomes · interdisciplinary approaches in cancer research · methods and models used in cancer research For questions relating to submissions on topics not listed above, please contact cancerreports@wiley.com Article types: Original article, brief report, method report, clinical study report, registered report, case report and review (literature and systematic). The journal will also publish timely editorials, commentaries and perspectives that will be commissioned by the Editor-in-Chief. For submission details click here. Manuscripts within the scope of the journal will be evaluated for publication solely on the bases of · evidence that the data support conclusions · adherence to technical and ethical standards
Catalog source: scimago. This is not a copy of the publisher's author instructions.
Submission & timeline
- Submission portal
- mc.manuscriptcentral.com/cancerreports
- Average review time
- Information not currently available.
- Acceptance rate
- Information not currently available.
- Article types accepted
- Information not currently available.
- Publication frequency
- Information not currently available.
General pre-submission checks for medical manuscripts
Generic checklist only — not journal-specific requirements.
- Confirm scope fit and intended article type on the official journal site.
- Abstract structure matches the journal's current requirements.
- Ethics approval and trial registration statements are complete.
- Informed consent and patient privacy statements are in place.
- Reporting guideline compliance (e.g. CONSORT, STROBE, PRISMA) as applicable.
- Reference style and citation limits per official guidelines.
- Figures and tables meet resolution, labeling, and count limits.
- Cover letter addresses novelty, fit, and required declarations.
- Conflicts of interest statement included.
- Funding statement included.
- Data availability statement included when required.